Columbia Care Completes $240 Million Acquisition Of Green Leaf Medical

Columbia Care Inc. (CSE: CCHW) announced today that it has completed the acquisition of cannabis multi-state operator Green Leaf Medical. The upfront consideration for the transaction is approximately US$240 million.

The acquisition price is composed of US$45 million in cash and US$195 million in Columbia Care shares, with additional potential performance-based milestones in the next two years.

Green Leaf’s financials will be immediately accretive to Columbia Care’s gross margin, adjusted EBITDA, and cash flow from operations. For Q1 2021, Green Leaf recorded approximately US$29 million in revenue, 50% gross margins, and a 30% adjusted EBITDA margin.

The acquisition also adds Green Leaf’s approximately 400,000 square feet of cultivation space across Pennsylvania, Maryland, Virginia, and Ohio to Columbia Care’s capacity, as well as four operational dispensaries and six dispensaries currently in development.

Last month, Columbia Care reported proforma Q1 2021 revenue of $92.5 million as Canaccord maintained the firm as one of its top cannabis firms picks.

Columbia Care Inc. last traded at $6.77 on the CSE.


Information for this briefing was found via Sedar and Columbia Care Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

P Diddy To Spend $185 Million Acquiring Cannabis Assets From Cresco Labs, Columbia Care

Cresco Labs (CSE: CL) appears to be monetizing the appointment of director Tarik Brooks, which...

Friday, November 4, 2022, 08:44:11 AM

Columbia Care Sees Consensus Price Target Rise To $14.70

On August 12, Columbia Care Inc. (CSE: CCHW) reported its second-quarter financial results, wherein the...

Wednesday, August 18, 2021, 10:09:00 AM

Cresco Labs To Pay US$2.0 Billion In Stock To Acquire Columbia Care

Consolidation within the US cannabis space continued this morning with the proposed combination of Columbia...

Wednesday, March 23, 2022, 07:58:57 AM

Columbia Care To Raise $130.0 Million Via Bought Deal Financing

Columbia Care (CSE: CCHW) (NEO: CCHW) is the latest US multi state operator to announce...

Friday, January 8, 2021, 07:42:17 AM

Columbia Care: Canaccord Drops Price Target To $13

On November 12th, Columbia Care (NEO: CCHW) reported its third quarter financial results. The company...

Sunday, November 21, 2021, 04:52:00 PM